Labiana Health S.A (LAB) | Stock Overview & Key Data
Labiana Health S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €6.95 on April 24, 2026
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Financial Highlights
Quarter Income Flow
Sep 30, 2022
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.24M Small-cap | 37.20% | 27.36% | 54.11% | 60.71% | 37.76% | 122.04% | 125.00% | 9,542.86% | 743.75% | 743.75% | 743.75% | |
|
Laboratorios
ROVI
|
4.34B Large-cap | -4.70% | 3.25% | 11.63% | 25.93% | 28.02% | 58.55% | 101.84% | 68.26% | 449.09% | 1,459.62% | 743.04% |
|
Almirall S.A
ALM
|
2.76B Large-cap | -0.47% | 11.78% | -0.16% | 0.79% | -1.40% | 31.68% | 36.63% | -2.60% | -9.40% | 65.19% | -15.31% |
|
Faes Farma S.A
FAE
|
1.51B Large-cap | -2.24% | 6.90% | -6.07% | 6.90% | -8.05% | 15.38% | 50.00% | 38.33% | 75.18% | 77.12% | -48.94% |
|
Laboratorio Reig
RJF
|
220.63M Mid-cap | -1.48% | 5.12% | -1.11% | -10.10% | -0.37% | -8.56% | 3.89% | -52.74% | -22.61% | -61.19% | -89.23% |
|
Grifols, S.A
GRF
|
6.09B Large-cap | -7.25% | 1.24% | -18.49% | -20.87% | -20.02% | 5.17% | -3.97% | -60.31% | -52.89% | 33.98% | 244.23% |
Ownership & Short Interest
Calculate Your Labiana Health S.A Investment Returns
Long-Term Investment Performance Analysis
Labiana Health S.A stock price in Nov 2016 was €0.80, A €1,000.00 lump sum investment in Labiana Health S.A made 9 years ago would be worth approximately €8,437.50 today, representing a exceptional return of 743.75%. This translates to an annualized return (CAGR) of 25.29%.
9 Years 5 Months Investment Scenario (Nov 2016 - Apr 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is LAB's 52-week high and low?
- In the last 52 weeks, Labiana Health S.A reached a high of €6.95 (on April 24, 2026) and a low of €2.80 (on April 25, 2025).
- What is the market cap and P/E ratio for LAB?
- Curious about Labiana Health S.A's size and valuation? Its market capitalization stands at 49.24M. When it comes to valuation, the P/E ratio (trailing twelve months) is 42.50, and the forward P/E (looking ahead) is 6.04.
- Does LAB pay dividends? If so, what's the yield?
- As for dividends, Labiana Health S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Labiana Health S.A's main competitors or similar companies to consider before investing?
When looking at Labiana Health S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Laboratorios
ROVI4.34B Healthcare Drug Manufacturers - Specialty & Generic 58.55% 101.84% Almirall S.A
ALM2.76B Healthcare Drug Manufacturers - Specialty & Generic 31.68% 36.63% Faes Farma S.A
FAE1.51B Healthcare Drug Manufacturers - Specialty & Generic 15.38% 50.00% Laboratorio Reig
RJF220.63M Healthcare Drug Manufacturers - Specialty & Generic -8.56% 3.89% Grifols, S.A
GRF6.09B Healthcare Drug Manufacturers - General 5.17% -3.97% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Labiana Health S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Labiana Health S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 23.11%, the Debt to Equity ratio from the most recent quarter is 998.21, and its Gross Profit Margin stands at 147.79%.
- What is the recent revenue and earnings growth for LAB?
- Looking at Labiana Health S.A's growth, its revenue over the trailing twelve months (TTM) was €72M. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.10%, and quarterly earnings saw a YoY growth of 54.80%.
- How much of LAB stock is held by insiders and institutions?
- Wondering who owns Labiana Health S.A stock? Company insiders (like executives and directors) hold about 61.15% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.49%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.